MYD88 and primary central nervous system lymphoma: In PCNSL, a ddPCR assay probing the hotspot MYD88 L265P mutation has a sensitivity rate of 60% in plasma samples39 and could potentially be used on cerebrospinal fluid (CSF) samples.